Untitled

Endogenous and Exogenous Definitions

  • Endogenous: Refers to substances or processes generated from within a biological system. Example: Leptin is a hormone that is naturally secreted within the body, affecting various physiological processes.

  • Exogenous: Refers to substances or actions originating from outside a biological system. Example: The intravenous injection of leptin represents an exogenous form of the hormone.

Hormone Action Types

  • Paracrine Signaling: A hormone function where the hormone is released and binds to receptors on nearby cells, influencing local physiology.

  • Endocrine Signaling: A hormone function where the hormone enters the bloodstream and targets receptors located throughout the body, impacting distant organs, such as the brain.

Key Terms and Definitions

  • Ligand: A molecule, such as a neuropeptide, that binds to another chemical entity, typically a receptor, to initiate or block a biological reaction. Ligands can be:

    • Endogenous: Produced naturally within the body (e.g., leptin).

    • Exogenous: Introduced from outside sources (e.g., modified drugs that interact with receptors).

  • Analog: A type of ligand that resembles another in structure but differs in a specific component, usually one that is not naturally present in the body.

  • Receptor Agonist: A ligand that binds to a receptor and triggers a biological response. Examples include leptin and CCK (cholecystokinin).

  • Receptor Antagonist: A ligand that binds to a receptor but does not provoke a biological response itself. Instead, it blocks or dampens the response mediated by agonists. This includes inverse agonists.

Paracrine Vagal Communication Overview

  • Hormonal Communication Pathway: Illustrates how hormones, nerve signals, and the central nervous system interact.

    • Components:

    • Hormone receptor

    • Nerve signal (electrical) directed to the central nervous system (CNS)

    • Relevant anatomical structures (e.g., Dorsal Medulla, Vagus Nerve) connected to various organs (e.g., lungs, liver, stomach, pancreas, colon, spleen, heart).

Blood-Brain Barrier (BBB)

  • Definition: The blood-brain barrier consists of a layer of endothelial cells that protect the brain from potentially harmful molecules circulating in the bloodstream.

  • Functionality:

    • Some small molecules can “leak” through the barrier.

    • Certain peptides or substances possess active transport systems that facilitate their entry into the brain, allowing for direct action within the CNS.

Circumventricular Organs

  • Example of Structures: Circumventricular organs, such as the Area Postrema, possess unique features allowing them to communicate directly with the bloodstream.

Neuroendocrine Pathway

  • Hormones Produced in the Brain: Some hormones like oxytocin, vasopressin, and corticotropin-releasing hormone are produced within the brain and then released into the peripheral bloodstream via the pituitary gland.

Stereotaxic Approach: Neuropharmacological Model

  • Definition: A stereotaxic approach involves the surgical implantation of a cannula, which is a tube inserted into the brain using a precise coordinate system to target specific regions.

  • Applications: This method allows for the introduction of small volumes of drugs, viruses, or neurotoxins into specific brain regions. Examples include injections into the cerebral ventricle or the ventromedial hypothalamus (VMH).

21st Century Applications of the Stereotaxic Approach

  • Gene Manipulation: Adeno-associated viruses (AAVs) can be used to introduce exogenous genes into neurons to manipulate their activity.

    • Optogenetics: A method that introduces light-sensitive ion channels to control neuronal activity using light. Fiber optic cannulas are utilized for light delivery.

    • Chemogenetics: Involves introducing new receptors to neurons for manipulation.

  • DREADDs (Designer Receptors Exclusively Activated by Designer Drugs):

    • Modified variant receptors (hM3Dq and hM4Di) introduced into neurons using AAVs or Cre-Lox methods. These receptors interact exclusively with designer drugs, leading to controlled neuronal activity.

Leptin and the Hypothalamus in Feeding Regulation

  • Functions of Leptin:

    • Discovered in 1994 by Jeffrey Friedman, leptin is a protein secreted from fat cells that directly controls appetite, body weight, and obesity.

    • Correlation with Body Fat: Plasma levels of leptin are directly correlated with body fat and Body Mass Index (BMI); however, exceptions do exist. Leptin exhibits diurnal and prandial (gastric) release patterns. Insulin stimulates leptin secretion from adipose tissues.

  • Lesions of the Ventromedial Hypothalamus:

    • Analysis of lesions demonstrates various feeding syndromes, including lateral hypothalamic syndrome and ventromedial hypothalamic syndrome.

Neuropeptides, Hormones, and Feeding

  • Table of Appetite-Regulating Molecules:

    • Locations of synthesis and actions of several appetite-regulating molecules, including:

    • Gastrointestinal Tract: Ghrelin, Peptide YY, CCK, GLP-1, etc.

    • Pancreas: Insulin, Amylin, etc.

    • Adipose Tissue: Leptin.

    • Hypothalamus: Neuropeptide Y, Orexins, and others.

Genetic Mutations Related to Leptin

  • Obesity-Related Mutations: A mutation of the leptin gene (ObOb) leads to extreme obesity in both humans and mice. The DbDb mutation affects the leptin receptor, also resulting in obesity.

Neural Doctrine of Feeding: Leptin and the Melanocortin System

  • Key Components:

    • Melanocortin 4 Receptor (MC4R): Located in the brain, agonists of MC4R reduce food intake and body weight.

    • AGRP (Agouti-Related Peptide): Produced in the hypothalamus' arcuate nucleus; stimulates food intake and acts as an MC4R antagonist.

    • POMC (Pro-opiomelanocortin): Precursor to alpha melanocyte-stimulating hormone (alpha MSH), which is an MC4R agonist.

Neuron Populations in the Hypothalamus

  • Two main neuron types identified:

    • Agrp/NPY Neurons: Inhibited by leptin, reducing the secretion of AGRP which antagonizes MC4R.

    • POMC/CART Neurons: Excited by leptin, increasing the secretion of alpha MSH, an MC4R agonist.

Stereotaxic Coordinates in Rat Brain Anatomy

  • Anatomical Reference: Coronal rat brain sections highlight important structures and the arcuate nucleus of the hypothalamus.

Mechanism of Leptin in Feeding Regulation

  • Endocrine Route: Leptin crosses the BBB from peripheral circulation and acts on receptors in the arcuate nucleus of the hypothalamus.

    • ALPHA MSH and AGRP Influence: Leptin activates POMC/CART producing neurons and inhibits AGRP neurons, modulating food intake and energy homeostasis.

Leptin's Mechanism of Action in Feeding Control

  • Stomach Secretions: Leptin is secreted from the stomach impacting vagus nerve receptors, sending neural signals to the NTS in the hindbrain.

  • Effects on Feeding Behavior:

    • Leptin increases satiation (meal termination) and decreases food-seeking behaviors (appetite).

Leptin Therapy for Obesity and Overeating

  • Challenges with Leptin Treatment:

    • Obese individuals often develop “leptin resistance,” where the mechanisms for leptin action become impaired.

    • BBB Transport Issues: Potential impairment of leptin transport due to short form of the leptin receptor functioning as a transport mechanism.

    • Cellular Level Resistance: Loss of intracellular signaling efficacy following leptin binding.

Mechanism of Cellular Leptin Resistance 2018 Revelation

  • Recent Findings: Obesity promotes the activity of matrix metalloproteinase-2 (Mmp-2) in the hypothalamus, cleaving the extracellular domain of the leptin receptor and impairing leptin signaling.